So, in this study, the CMap analysis was performed to predicate three small molecule drugs that could potentially be targeted as a therapeutic drug HOXB7, further suggesting that HOXB7 could be a novel therapeutic target in HNSCC. Here, HOXB7 is linked to head and neck squamous cell carcinoma.